- GTIN
CROSS-MARKET MEDICINE COMPARISON
Compare medicine products across countries.
Medimapper helps pharmaceutical distribution and portfolio teams compare marketed medicines across countries. Compare local code and pack with substance, strength, form, manufacturer and brand. Every result links back to its source.
66 countriesSource-linked resultsPlatform and API included
Product-presence intelligence, not live stock, proven demand, clinical equivalence or trade authorisation.
THE COMPARISON, END TO END
How it works.
Loading animation
START WITH YOUR COMMERCIAL QUESTION
Choose the workflow that matches your decision.
Medimapper uses one shared data and comparison model, but the question is different for a sourcing team and a portfolio team. Start with the products and markets you are actively evaluating.
Compare a live source-target corridor.
Send five products and the source and target markets you are evaluating. See the strongest comparable product candidates, the attributes that align and the pack, code, manufacturer and price differences that remain.
Map product presence across target markets.
Send ten products or substances and the target regions you want to review. See which comparable presentations are already marketed, which manufacturers and brands are present and where deeper demand, access and regulatory research may be useful.
FROM LOCAL RECORD TO TARGET-MARKET CANDIDATES
See what aligns, and what still differs.
- Source-market product
- Shared substance identity
- Normalised presentation
- Target-market candidates
- Visible pack and commercial differences
Medimapper does not collapse national products into one global record. It connects them through shared substance identity and compares the attributes that matter for the question at hand.
The result is a shortlist for commercial and regulatory follow-up, supported by local source records and transparent match levels.
Download a sample comparison
A focused dataset for quetiapine, risperidone and olanzapine. See how local records connect across markets, and where substance, presentation and pack attributes still differ.
BEFORE YOU REQUEST A PROOF
See the coverage, the access channels and the price.
Country and field coverage
Medimapper covers 66 countries. Available sources and fields differ by country.
Platform, API and MCP
Search and compare in the platform, export a focused report, or bring the same licensed data into an internal workflow.
Regional annual subscriptions
Choose the regions you need. Platform, API, MCP, reports and exports are included for the licensed countries and fields in your agreement.
BUILT ON PHARMACEUTICAL PRODUCT-DATA EXPERIENCE
Developed by the team behind Medipim.
Medimapper is developed by the team behind Medipim. Years of working with national pharmaceutical sources and product-data workflows shaped the way Medimapper handles identity, provenance, local context and data responsibility.
START WITH YOUR PRODUCTS
Show us the products and markets you are evaluating.
We will review the relevant coverage and propose the right proof: a Five-Product Market Match or a Portfolio Presence Scan.